Teladoc Health, Inc. (NYSE:TDOC - Get Free Report)'s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $9.70, but opened at $10.36. Teladoc Health shares last traded at $10.01, with a volume of 2,335,899 shares traded.
Analyst Ratings Changes
A number of research firms have issued reports on TDOC. Royal Bank of Canada raised their price target on shares of Teladoc Health from $9.00 to $10.00 and gave the stock an "outperform" rating in a report on Wednesday, October 9th. Barclays upped their target price on Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a research report on Thursday, October 31st. TD Cowen lowered their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, October 31st. Evercore ISI increased their price objective on Teladoc Health from $8.00 to $9.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. Finally, The Goldman Sachs Group started coverage on Teladoc Health in a research note on Friday, November 15th. They issued a "buy" rating and a $14.00 price objective for the company. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $12.24.
View Our Latest Stock Analysis on TDOC
Teladoc Health Stock Performance
The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm has a market capitalization of $1.58 billion, a PE ratio of -1.59 and a beta of 1.01. The firm's 50 day moving average price is $9.99 and its 200-day moving average price is $9.03.
Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. On average, research analysts expect that Teladoc Health, Inc. will post -1.16 EPS for the current year.
Insider Buying and Selling
In related news, insider Carlos Nueno sold 2,389 shares of the firm's stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the transaction, the insider now directly owns 2,890 shares of the company's stock, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.95% of the stock is owned by insiders.
Hedge Funds Weigh In On Teladoc Health
A number of hedge funds have recently made changes to their positions in TDOC. Versant Capital Management Inc boosted its stake in shares of Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after acquiring an additional 2,441 shares during the last quarter. Blue Trust Inc. boosted its stake in Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock worth $40,000 after purchasing an additional 1,854 shares during the last quarter. Doheny Asset Management CA acquired a new stake in Teladoc Health during the 2nd quarter worth $46,000. Benjamin F. Edwards & Company Inc. grew its holdings in shares of Teladoc Health by 209.8% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider's stock worth $49,000 after buying an additional 3,396 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. raised its position in shares of Teladoc Health by 194.2% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,891 shares of the health services provider's stock valued at $67,000 after buying an additional 4,549 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
